Monday, March 10, 2025
spot_img

Bread Financial Announces Approval of $150 Million Share Repurchase Program

COLUMBUS, Ohio, March 05, 2025 (GLOBE NEWSWIRE) — Bread Financial® Holdings, Inc. (NYSE: BFH) (“Bread Financial” or the “Company”) today announced that its Board of Directors (the “Board”) has authorized a new plan to repurchase up to $150 million of shares of its common stock. There is no expiration date for the repurchase plan.

“Aligned with our capital priorities, we have prudently focused on strengthening our balance sheet over the past five years, including building capital and reducing debt. The issuance of Tier 2 capital and this share repurchase authorization will further strengthen our total capital ratios, while providing capital flexibility for future growth and further optimization of our capital position over time,” said Ralph Andretta, president and chief executive officer of Bread Financial.

Any decision to repurchase shares will be subject to market conditions and other factors, including legal and regulatory restrictions and required approvals, up to the aggregate amount authorized by the Board. The repurchase plan does not obligate the Company to acquire any specific number of shares and may be suspended or terminated at any time.

About Bread Financial®
Bread Financial® (NYSE: BFH) is a tech-forward financial services company that provides simple, personalized payment, lending and saving solutions to millions of U.S. consumers. The Company’s payment solutions, including Bread Financial general purpose credit cards and savings products, empower its customers and their passions for a better life. Additionally, the Company delivers growth for some of the most recognized brands in travel & entertainment, health & beauty, jewelry and specialty apparel through their private label and co-brand credit cards and pay-over-time products providing choice and value to their shared customers.

Forward-Looking Statements
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including, among other things, statements regarding the Company’s intended share repurchases and the expected impact on share count dilution. The Company believes that its expectations are based on reasonable assumptions. Forward-looking statements, however, are based only on currently available information and the Company’s current beliefs, expectations and assumptions, and are subject to a number of risks and uncertainties that are difficult to predict and, in many cases, beyond the Company’s control, including risk and uncertainties described in greater detail under the headings “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s Annual Report on Form 10-K for the most recently ended fiscal year, which may be updated in Item 1A of, or elsewhere in, the Company’s Quarterly Reports on Form 10-Q filed for periods subsequent to such Form 10-K. The Company’s forward-looking statements speak only as of the date made, and it undertakes no obligation, other than as required by applicable law, to update or revise any forward-looking statements, whether as a result of new information, subsequent events, anticipated or unanticipated circumstances or otherwise.

Contacts

Brian Vereb — Investor Relations
[email protected] 

Susan Haugen — Investor Relations
[email protected] 

Rachel Stultz — Media
[email protected]  

Powered by SlickText.com

Hot this week

Correction: Final terms for bonds to be listed 11th March 2025: New final terms attached

To Nasdaq Copenhagen A/S                        10th March 2025                                        Announcement no. 22/2025Final terms...

First Patient Enrolled in Merit Medical’s PREEMIE Study

Multicenter, prospective study designed to evaluate safety and efficacy...

VIVOPOWER ACTIVATES AND EXTENDS STOCK BUYBACK PROGRAM OF UP TO US$5 MILLION (UPDATED)

Stock Buyback Program commencing from today, with broker engaged...

PharmAla Signs Duchefa Farma as Exclusive Distributor in Netherlands

TORONTO, March 10, 2025 (GLOBE NEWSWIRE) --...

Topics

Correction: Final terms for bonds to be listed 11th March 2025: New final terms attached

To Nasdaq Copenhagen A/S                        10th March 2025                                        Announcement no. 22/2025Final terms...

First Patient Enrolled in Merit Medical’s PREEMIE Study

Multicenter, prospective study designed to evaluate safety and efficacy...

VIVOPOWER ACTIVATES AND EXTENDS STOCK BUYBACK PROGRAM OF UP TO US$5 MILLION (UPDATED)

Stock Buyback Program commencing from today, with broker engaged...
spot_img

Related Articles

Popular Categories

spot_img